Dexcom on Tuesday announced an artificial intelligence feature for its Stelo continuous glucose monitor that gives users a personalized look into how meals, sleep and activity impact their glucose levels. It’s the first iteration of a new generative AI platform that the company has been building with Google Cloud. 

Stelo is an over-the-counter CGM that pokes through the skin to measure real-time blood sugar levels. The sensor launched in August and can be used by any adult who doesn’t take insulin. 

The report reflects Dexcom’s effort to make Stelo more personalized and engaging for consumers as it works to penetrate a new market. 

“The No. 1 feedback we get is users want to see more,” Jake Leach, chief operating officer at Dexcom, told CNBC in an interview. “They’re making an investment and wearing the product, and they want to be able to take the most advantage of all the data that they’re generating.”

Dexcom is using Google’s Gemini models and its Vertex AI platform as the foundation for its new AI offering. Vertex AI allows developers to build applications that synthesize different types of data, which can be notoriously challenging in health care. 

Leach said Dexcom is also exploring how its generative AI platform can be used across its other CGM products, but the company is proceeding extra carefully since patients rely on them to prevent medical emergencies. 

“It really felt like Stelo was the right place to do this for the first time,” he said.

An existing insights report has already been available to users within the Stelo app, but it followed a more standard template format each week. Dexcom believes the AI-generated report will be more valuable to users since it’s personalized, Leach said. 

If there’s a week where a user is not moving enough after meals, for instance, the report would include relevant tips and educational materials to help. 

Stelo’s AI reports don’t give users medical advice, though Dexcom has been using an AI framework from the U.S. Food and Drug Administration to help guide the feature’s development, Leach said. The FDA approved Stelo in March. 

Eventually, Dexcom wants to use its generative AI platform to deliver real-time feedback to users instead of just weekly reports. The company is also exploring how the technology could act as a predictive indicator for potential problems, much like a check engine light on a car. 

“It gives you a sense for what could be going on, and recommendations of where you might want to go to seek more advice,” Chris Sakalosky, vice president of strategic industries for Google Cloud, told CNBC in an interview.   

Dexcom’s updated weekly report began rolling out to Stelo users this week.

Databricks, one of the most valuable privately held companies, announced a $10 billion financing on Tuesday that values the software maker at $62 billion. 

With the money, Databricks will be able to provide liquidity to current and former employees, make acquisitions, and expand overseas, according to a statement. The company’s new valuation is up from $43 billion in 2023. Rival Snowflake was worth about $57 billion at Monday’s close.

Databricks sells software for analyzing and cleaning up data, and it also runs artificial intelligence models for clients. The software is available on the Amazon, Google and Microsoft clouds, which are also competitors. 

The company expects to generate positive free cash flow for the first time with a $3 billion revenue run rate in the quarter that ends on Jan. 31, Databricks said. The company’s revenue in the October quarter grew more than 60% year over year.

Investors in the financing, of which it has raised $8.6 billion to date, include Thrive Capital, Andreessen Horowitz, DST Global, GIC, Iconiq Growth, Insight Partners, MGX, Sands Capital, WCM Investment Management and Wellington Management.

Technology investors have been anticipating a Databricks initial public offering for years. They may only have to wait a few more months.

ServiceTitan, a company with software for plumbers and others working in the trades, raised about $625 million in an initial public offering last week, and some investors have predicted that tech IPOs will become more frequent again in 2025 after a relative drought since late 2021.

Databricks did not offer new information about its expectations for an IPO on Tuesday.

“If we were going to go, the earliest would be, let’s say mid next year or something like that,” Ali Ghodsi, Databricks’ co-founder and CEO, said at the Cerebral Valley AI Summit in November.

Late-stage investors with large funds don’t have many options for what to back, Ghodsi said. 

“There’s nowhere to put it, really, except maybe Databricks, Stripe or, you know, maybe OpenAI,” Ghodsi said.

Databricks made its fourth appearance on CNBC’s Disruptor 50 list of private companies in 2024.

Nvidia shares fell in premarket trading on Tuesday, as Broadcom continued its rapid surge higher.

Nvidia stock was down about 1.8% in premarket trading at 10:47 a.m. London time. On Monday, the company a entered correction territory — broadly defined as the point when a stock falls 10% or more from an all-time high close.

Nvidia hit its closing high of $148.88 last month.

In a tale of two chip stocks, Broadcom shares were 1.9% higher at 10:50 a.m. London time in premarket trade. Over the past five days alone, Broadcom shares have rallied 40%, while those of Nvidia have surrendered 5%.

Bullishness around Broadcom has been fuelled by the company’s release last week of fourth-quarter earnings that exceeded expectations and a revenue outlook for the current quarter that beat forecasts. A number of Wall Street brokers, including Goldman Sachs, have raised their price targets on Broadcom’s stock recently.

Broadcom shares have risen more than 120% this year to date, while Nvidia’s stock has added more than 160% over the same period.

This breaking news story is being updated.